ABSTRACT Occupationally related asthma developing in three patients due specifically to exposure to 1,5-naphthylene di-isocyanate (NDI), a hot curing agent used in manufacturing rubber, has been confirmed for the first time using bronchial provocation testing. This substance has been thought to be safer than toluene di-isocyanate (TDI) and diphenylmethane di-isocyanate (MDI) because of its relatively high melting point (1200C).
Respiratory symptoms resulting from exposure to di-isocyanates have been recognised since the first report by Fuchs and Valade (1951) of reactions to toluene di-isocyanate (TDI). Symptoms of asthma may follow inhalation of the vapour of these compounds. The more volatile isocyanates, TDI and hexamethylene di-isocyanate (HDI), cause asthma at room temperature while solid isocyanates, diphenylmethane di-isocyanate (MDI) and 1, 5-naphthylene di-isocyanate (NDI) seldom cause problems unless they are heated (Longley, 1964; Munn, 1965; Tanser, 1973) .
NDI is a solid with a melting point of 1200C. Goldblatt and Goldblatt (1956) and Munn (1965) both describe instances in which the development of asthma was thought to result from exposure to the vapour of NDI. We describe three patients in whom asthma developed for th-first time while they were working in a factory where various isocyanates were used and whose asthma was thought to be caused by the vapour of NDI, a hot curing agent used in manufacturing synthetic rubber. Using occupational-type bronchial provocation testing these symptoms were shown to result specifically from exposure to NDI vapour. This 37-year-old man worked for six years as a moulder of plastic and then as a polyurethane caster at the same factory as the first patient both at its old location and the new one. Two years before attending hospital he was moved on the shop floor to take the place of patient 2 who had by then been shown to be sensitised to NDI. After this move he developed increasing shortness of breath and wheeze worse at night and better away from work when on holiday, but not at weekends. He had attributed his symptoms to smoking 30 cigarettes a day. He was non-atopic.
He was admitted to hospital for bronchial provocation testing in April 1978.
Bronchial provocation testing
Since each of the patients tested was known to have been exposed to TDI, MDI, and NDI, sensitisation to any or all of these three isocyanates was possible. The exposure techniques with TDI and MDI as well as histamine and exercise testing have been described elsewhere (O'Brien et al, 1979b Isocyanate asthma: respiratory symptoms due to 1,S-naphthylene di-isocyanate Sensitisation to isocyanate depends on several factors including the nature of exposure and the reactivity of the patient. The nature of exposure in all three was similar since they all worked in the same factory and patients 2 and 3 did identical jobs.
The reactivity of the patient judged by his atopic status, exercise tolerance, and histamine reactivity does not correlate well with proneness to sensitisation but O'Brien et al (1979a) have shown that those subjects highly sensitive to TDI reacting to levels less than 0-001 ppm did have increased bronchial lability to histamine. None of the subjects we tested had exercise asthma, and none of them reacted to TDI at an atmospheric level less than 0-001 ppm. Only the first patient reacted to histamine at a final concentration of 32 mg/ml with a 20% fall in FEV1.
The mechanism of sensitisation to isocyanates is unclear, but both allergic and pharmacological mechanisms have been suggested. Karol et al (1978) have found IgE antibodies against the tolyl group of TDI suggesting that isocyanates are haptogenic with the reactive portion, the NCO group, binding with serum proteins, and Zeiss et al (1979) has found specific IgE and IgG antibody to human serum albumen MDI conjugates in two patients sensitised to MDI. Butcher et al (1976) and Davies et al (1977) on the other hand have suggested that TDI acts as a beta-adrenergic receptor antagonist based on its inhibitory effect on isoprenaline-induced increase in the 3,5 cyclic AMP level in lymphocytes.
A major problem in the interpretation of asthmatic reactions to the various isocyanates is knowing to which of them the patient has been exposed in the past. Many of the industrial processes used are highly secret, and the patient may not know what chemicals are being used. Furthermore, one isocyanate may be contaminated by small quantities of another, to which some individuals may react at very low atmospheric concentrations.
Though advised to give up work immediately evidence of sensitisation had been demonstrated, only one of our patients felt able to accept this advice. The reason for this was difficulty in finding alternative employment; the patient who left is still unemployed. Follow-up in the two who remained exposed shows persistent airway narrowing, and now three months after avoidance of known exposure in one of these there is still evidence of reversible airways obstruction. Prolonged measurement of peak flow rates at home and at work in sensitised patients exposed to TDI has shown a recovery pattern longer than 70 days in some cases (Burge et al, 1979) .
